A new report from RnR MarketResearch delves into the therapeutic development for spinal cord injury.
The report, “Spinal Cord Injury – Pipeline Review, H2 2015,” includes comparative analysis at various stages; therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with the latest updates; and featured news and press releases, according to a media release from RnR MarketResearch.
The research included in the report reviews key players involved in the therapeutic development for spinal cord Injury and special features on late-stage and discontinued projects, per the release.
For more information, visit RnR MarketResearch.
[Source(s): RnR MarketResearch, PR Newswire]
